IMF Patient & Family Webinar 2023 - Understanding The New Myeloma Landscape - Eastern (https://www.myeloma.org/videos/imf-patient-family-webinar-2023-new-myeloma-landscape)
What to Expect from this Patient and Family Webinar
This webinar covers both the basics of diagnosis and early treatment as well as excitement around new immune therapies. The importance of expert management of infections is an area of particular focus.
- A discussion of MGUS, smoldering myeloma and active myeloma
- Learn more about when patients may consider beginning treatment
- Listen to presentation on tests for diagnosis and monitoring, how the disease is staged, and more
- Hear advice for side effects / symptom management
- Outline the most common side effects / toxicities brought about by new and emerging therapies
- Including a focus on autologous stem cell transplant
- Discussion on triplets vs quadruplets in treatment
- Discussing the recent FDA approval of the first-in-class bispecific T-cell engager Tecvayli™ (teclistamab-cqyv) for the treatment of adult patients with relapsed or refractory multiple myeloma
- Practical guidance will be provided regarding the many new myeloma treatment options, including the best sequencing of these options and their potential side effects
- Exploring the latest treatment options available in clinical trials today
At the end of each presentation, participants will have time to ask questions
Patient and Family Webinar Sponsors:
with support from:
AbbVie, Amgen, BMS, Genentech, GSK, Janssen, Karyopharm Therapeutics, Pfizer, Regeneron, Sanofi, Takeda Oncology, and The Binding Site
Please check out these multiple myeloma resources from our sponsors:
(All the sponsor links below are external links and you acknowledge that you are leaving the IMF website. The IMF is not responsible for content provided by the links below and you may be subject to the Privacy Policy and Terms & Conditions of the destination site(s).)
